Rezuforimod
瑞佐福莫德
Report date: 2026/04/17 20:02:02
NME
Base Information
Drug NameRezuforimod
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A
Develop Information
Active CompaniesAllgenesis Biotherapeutics Inc
Inactive CompaniesAllergan Plc
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A